➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Moodys
Harvard Business School
Express Scripts
Merck

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

RASAGILINE MESYLATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Rasagiline Mesylate, and what generic alternatives are available?

Rasagiline Mesylate is a drug marketed by Alkem Labs Ltd, Apotex Inc, Indoco Remedies, Micro Labs, Mylan, Orchid Hlthcare, Sandoz Inc, and Watson Labs Inc. and is included in eight NDAs.

The generic ingredient in RASAGILINE MESYLATE is rasagiline mesylate. There are eighteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the rasagiline mesylate profile page.

US ANDA Litigation and Generic Entry Outlook for Rasagiline Mesylate

A generic version of RASAGILINE MESYLATE was approved as rasagiline mesylate by ORCHID HLTHCARE on March 15th, 2016.

  Start Trial

Drug patent expirations by year for RASAGILINE MESYLATE
Drug Prices for RASAGILINE MESYLATE

See drug prices for RASAGILINE MESYLATE

Recent Clinical Trials for RASAGILINE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Teva Pharmaceutical IndustriesPhase 1
Technische Universität DresdenPhase 4
Teva Pharmaceutical IndustriesPhase 4

See all RASAGILINE MESYLATE clinical trials

Pharmacology for RASAGILINE MESYLATE

US Patents and Regulatory Information for RASAGILINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201889-001 Oct 30, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Micro Labs RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 207004-001 Mar 29, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201950-002 Sep 12, 2013 DISCN No No   Start Trial   Start Trial   Start Trial
Orchid Hlthcare RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 201970-002 Mar 15, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Micro Labs RASAGILINE MESYLATE rasagiline mesylate TABLET;ORAL 207004-002 Mar 29, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Baxter
Medtronic
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.